Category: Treatment for COVID-19
-
Didier Raoult takes hydroxychloroquine battle to court
Didier Raoult, director of the IHU, the Institute of Infectious Diseases in Marseille and one of the first to champion the use of hydroxychloroquine (HCQ) for COVID-19 treatment, has filed a complaint against the National Agency for the Safety of Medicines and Health Products (ANSM). Raoult’s legal representative, Fabrice di Vizio, states that the French…
-
America’s Frontline Doctors Holds Second White Coat Summit
The following article from The Published Reporter covers the second White Coat Summit by America’s Frontline Doctors. The summit was held last October 16-17, 2020 on the steps of the Supreme Court of the United States in Washington, D.C. For this summit, the doctors focused the discussion on masks, lockdowns, and early treatment. Dr. Simone…
-
Here is Saudi Ministry of Health’s protocol for COVID-19
The following is a document retrieved from Saudi Arabia’s Ministry of Health (MoH). It summarizes the protocol for patients who are suspected of, or are confirmed to have COVID-19. Some of the highlights of this document include the following: (1) patients presenting with COVID-like symptoms are not automatically treated as COVID patients. Infectious diseases experts…
-
Hydroxychloroquine: Uganda’s secret weapon against COVID-19
The following article was published by The Palmer Foundation last August 19, 2020. It explains how Uganda, one of the poorest countries in the world, and having one of the worst health care systems in Africa, has not experienced the expected surge of COVIDcases and COVID deaths. Editor’s Note: This article has become relevant again…
-
Hydroxychloroquine can dramatically ease the COVID-19 crisis
Last September 17, 2020, the Concerned Doctors and Citizens in the Philippines (CDC-PH) held a press conference entitled Flatten The Fear. Their goal? To call for the end of all lockdowns and the implementation of a national protocol for early treatment of patients with COVID-like symptoms. [See videos below if you wish to understand the…
-
New study: Hydroxychloroquine is effective and safe for the treatment of COVID-19
The following is a meta-analysis of various reports that used hudroxychloroquine (HCQ) for COVID-19 treatment. Based on their research, authors Chadwick Prodromos and Tobias Rumschlag offers these four important results: (1) HCQ is consistently effective for COVID-19 when used early in the course of the disease. The earlier it is used, the more effective it…
-
Recommendation for physicians and authorities for the treatment of COVID-19
The following article was published by the Swiss Policy Research (SPR) last July 2, 2020 and was updated last September 4, 2020. In it, SPR offers a protocol for the treatment of COVID-19. The website says that this protocol has been developed through available evidence and clinical experience. SPR also explains why and how specific drugs…
-
Dr. Harvey Risch: Dr. Fauci and the FDA has caused the deaths of hundreds of thousands of Americans
In an article for Tech Startups last August 24, 2020, Nickie Louise interviews Dr. Harvey Risch who has recently been a subject of much criticism after the Newsweek published his article [see The key to overcoming COVID-19 already exists]. Dr. Risch says that there are at least 53 studies showing that hydroxychloroquine has positive results among those…
-
AAPS: Countries using hydroxychloroquine have lower coronavirus fatality rate
When the Association of American Physicians and Surgeons (AAPS) filed its motion for a preliminary injuction against the FDA and the Department of Health and Human Services (HHS) in June, it included a chart which showed that countries that use HCQ use had lower fatality rate [to learn about the law suit, read AAPS sues…
-
PITAHC supports “tuob”
A statement released by the Philippine Institute of Traditional and Alternative Health Care (PITAHC) last June 30, 2020 supported the use of tuob or steam inhalation to alleviate the respiratory illness commonly experienced by patients with mild COVID-19 symptoms. Editor’s Note: While this statement was released more than a month ago, it has not been…
